Nexsen Limited (ASX:NXN)
Australia · Delayed Price · Currency is AUD 0.2650
0.00 (0.00%)
Last updated: Jul 7, 2026, 10:26 AM AEST
Nexsen Market Cap
Nexsen has a market cap or net worth of 53.05 million as of July 6, 2026.
Market Cap
53.05M
Enterprise Value
46.17M
Revenue
931.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 53.05M, a decrease of -5.36%. That is a compound annual growth rate of -7.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 61.06M | 90.63% |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 91.95M |
| Avecho Biotechnology | 88.10M |
| Arovella Therapeutics | 83.41M |
| Immutep | 81.05M |
| Amplia Therapeutics | 77.00M |
| Prescient Therapeutics | 71.50M |
| Radiopharm Theranostics | 70.88M |
| Botanix Pharmaceuticals | 57.42M |